A 2010 study estimated the capitalized and direct costs of bringing a single new drug to market at approximately US$1.8 billion and US$870 million, respectively.
Utafiti mmoja katika mwaka wa 2010 uligundua gharama za ziada na zisizokuwa na marejesho za kuleta dawa moja moya kwa soko kukaribia dola bilioni 1.8 na dola milioni 870, mtawalia.